The Herbert and Florence Irving Institute for Cancer Dynamics will continue its seminar series on the topic of mathematical sciences underpinning cancer research. The monthly seminars take place on the second Wednesday of the month, 2:00-3:00 PM EST. The presentations are open to the Columbia community (in person and online) and to researchers outside Columbia (via Zoom).
On Wednesday, November 12th (2:00 PM ET), IICD welcomes Dr. Ken Chen from The University of Texas MD Anderson Cancer Center. Seminar hosted by Dr. Khanh Dinh. The seminar will take place in person in Schermerhorn Hall 603 (Morningside Heights campus). If you wish to attend the seminar remotely, please register using the following link: https://columbiauniversity.zoom.us/meeting/register/MJQS81yBS-KWSoJ-fb2E1g
Title: TBA
Abstract: TBA
Bio: Dr. Ken Chen is currently a tenured professor of Bioinformatics and Computational Biology at MD Anderson Cancer Center in Houston, Texas. He is a fellow of the American Institute of Medical and Biological Engineering (AIMBE) and a fellow of the Asia-Pacific Artificial Intelligence Association (AAIA). Having a background in machine learning, statistical signal processing, bioinformatics, and genomics, his primary interest is to develop computational tools to analyze and interpret human genomics and clinical data towards the realization of genomic medicine. Dr. Chen has designed, developed, and co-developed a set of computational tools such as BreakDancer, novoBreak, monoVar, SiFit, TransVar, BreakTrans, BreakFusion, TIGRA, CREST, PolyScan, SomaticSniper, and VarScan, which have been widely applied to characterize individual and population genomics in various large-scale sequencing projects such as those in The Cancer Genome Atlas (TCGA), the 1000 Genomes Project and Human Cell Atlas. He is particularly interested in comprehensively and accurately constructing the genomes and the transcriptomes of various cancer and immune cell populations with a focus on structural variants, towards understanding the heterogeneity and the evolution of cancer and tumor microenvironment as a consequence of genetics and treatment. He is also interested in correlating genomics with diseases towards identifying biomarkers that are useful for personalized diagnosis and prognosis.
If you would like to meet one-on-one (possibly via Zoom) or attend the lunch or dinner with the speaker, please contact the event organizer.